PitchSend

Investor Presentaiton

Expanding opportunity Significant capital needs Innovative funding Facilitating M&A Differentiated sourcing Industry fragmentation and complexity drive royalty creation License Royalties Large Pharma Synthetic royalties (~25 companies) ROYALTY PHARMA ROYALTY PHARMA L&D: launch & development capital Academia / non-profit (>5,000 labs) ROYALTY PHARMA Royalties License Biotechs (>8,000 companies) Royalties License & Partner, M&A Synthetic royalties, L&D capital ROYALTY PHARMA 33

View entire presentation